Angion Biomedica Correlations
| ANGNDelisted Stock | USD 10.00 8.94 843.40% |
The current 90-days correlation between Angion Biomedica Corp and Apollomics Class A is -0.11 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Angion Biomedica moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Angion Biomedica Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Angion Biomedica Correlation With Market
Average diversification
The correlation between Angion Biomedica Corp and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Angion Biomedica Corp and DJI in the same portfolio, assuming nothing else is changed.
Angion |
Moving together with Angion Stock
| 0.76 | KB | KB Financial Group | PairCorr |
| 0.68 | BMA | Banco Macro SA | PairCorr |
| 0.8 | PLTR | Palantir Technologies Aggressive Push | PairCorr |
| 0.78 | DIS | Walt Disney Aggressive Push | PairCorr |
| 0.81 | CVX | Chevron Corp Sell-off Trend | PairCorr |
| 0.78 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.67 | HPQ | HP Inc | PairCorr |
| 0.76 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.61 | T | ATT Inc Aggressive Push | PairCorr |
| 0.9 | JPM | JPMorgan Chase Sell-off Trend | PairCorr |
| 0.89 | BAC | Bank of America Aggressive Push | PairCorr |
Moving against Angion Stock
| 0.81 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.73 | NVO | Novo Nordisk AS | PairCorr |
| 0.72 | NONOF | Novo Nordisk AS | PairCorr |
| 0.71 | AULT | Ault Alliance Symbol Change | PairCorr |
| 0.7 | CSLLY | CSL | PairCorr |
| 0.68 | CMXHF | CSL Limited | PairCorr |
| 0.68 | QSAM | Qsam Biosciences | PairCorr |
| 0.65 | VLCN | Volcon Inc | PairCorr |
| 0.43 | AKO-B | Embotelladora Andina | PairCorr |
| 0.79 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.75 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.39 | MMM | 3M Company Fiscal Year End 28th of January 2025 | PairCorr |
| 0.39 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Angion Stock performing well and Angion Biomedica Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Angion Biomedica's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| EFTR | 7.57 | (4.57) | 0.00 | (470.75) | 0.00 | 8.70 | 88.91 | |||
| LABP | 3.55 | 0.43 | 0.09 | 0.58 | 3.81 | 8.58 | 19.47 | |||
| APGN | 5.12 | 0.10 | 0.00 | (1.01) | 5.50 | 7.89 | 58.79 | |||
| NAVB | 6.04 | (1.01) | 0.00 | 1.31 | 0.00 | 12.50 | 40.40 | |||
| ONCR | 8.13 | (2.39) | 0.00 | (0.97) | 0.00 | 10.00 | 120.67 | |||
| APLM | 6.40 | 0.07 | 0.00 | 0.01 | 0.00 | 8.40 | 134.75 | |||
| SGTX | 14.93 | 4.84 | 0.72 | 0.55 | 6.43 | 12.46 | 442.39 | |||
| PYXS | 3.89 | (0.76) | 0.00 | (10.48) | 0.00 | 6.41 | 61.13 | |||
| ZURA | 3.79 | (0.66) | 0.00 | (0.19) | 0.00 | 7.95 | 26.70 | |||
| CYTO | 3.53 | (1.15) | 0.00 | (8.98) | 0.00 | 6.98 | 22.81 |
View Angion Biomedica Related Equities
| Risk & Return | Correlation |
Angion Biomedica Corporate Management
| Daniel Iazzetti | VP HR | Profile | |
| Jennifer JD | Chief VP | Profile | |
| Bruce Rich | Assistant Sec | Profile | |
| Gregory Curhan | Chief Officer | Profile | |
| MBA MD | CEO Pres | Profile |
Still Interested in Angion Biomedica Corp?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.